» Authors » Christiane Kuempers

Christiane Kuempers

Explore the profile of Christiane Kuempers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 170
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thunnissen E, Blaauwgeers H, Filipello F, Lissenberg-Witte B, Minami Y, Noguchi M, et al.
Lung Cancer . 2025 Jan; 199:108060. PMID: 39793325
Objectives: Evaluating invasion in non-mucinous adenocarcinoma (NMA) of the lung is crucial for accurate pT-staging. This study compares the World Health Organization (WHO) with a recently modified NMA classification. Materials...
2.
Kuempers C, Schnepf K, Marwitz S, Watermann C, Scheel A, Fischer R, et al.
Histol Histopathol . 2024 Mar; 39(7):867-876. PMID: 38529720
Introduction: Lung cancer is a major cause of cancer-related death worldwide and effective therapies, besides surgery, are available only for a small proportion of patients. Since cellular respiration is known...
3.
Kuempers C, Jagomast T, Paulsen F, Heidel C, Bohnet S, Schierholz S, et al.
Histol Histopathol . 2023 Jul; 39(4):437-446. PMID: 37409491
Background: Despite promising results of targeted therapy approaches, non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related death. Tripartite motif containing 11 (TRIM11) is part of the TRIM...
4.
Salcher S, Sturm G, Horvath L, Untergasser G, Kuempers C, Fotakis G, et al.
Cancer Cell . 2022 Nov; 40(12):1503-1520.e8. PMID: 36368318
Non-small cell lung cancer (NSCLC) is characterized by molecular heterogeneity with diverse immune cell infiltration patterns, which has been linked to therapy sensitivity and resistance. However, full understanding of how...
5.
Kuempers C, Jagomast T, Heidel C, Paulsen F, Bohnet S, Schierholz S, et al.
Front Oncol . 2022 Oct; 12:927140. PMID: 36212402
Aim: Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related death globally despite promising progress of personalized therapy approaches. Cyclin-dependent kinase 7 (CDK7) is a kinase involved in...
6.
Kuempers C, Jagomast T, Krupar R, Paulsen F, Heidel C, Ribbat-Idel J, et al.
Front Med (Lausanne) . 2021 Oct; 8:734901. PMID: 34692726
Rovalpituzumab tesirine (Rova-T), an antibody-drug conjugate directed against Delta-like protein 3 (DLL3), is under development for patients with small cell lung cancer (SCLC). DLL3 is expressed on the majority of...
7.
Ellebrecht D, Kuempers C, Perner S, Kugler C, Kleemann M
Biomed Tech (Berl) . 2021 Jun; 66(3):285-292. PMID: 34062634
Cancer will be the leading cause of death in a few decades. In line with minimal invasive lung cancer surgery, surgeons loose most of their tactile tissue information and need...
8.
Pasternack H, Kuempers C, Deng M, Watermann I, Olchers T, Kuehnel M, et al.
Sci Rep . 2021 May; 11(1):9532. PMID: 33953302
The only potentially curative treatment for lung adenocarcinoma patients remains complete resection of early-stage tumors. However, many patients develop recurrence and die of their disease despite curative surgery. Underlying mechanisms...
9.
Offermann A, Roth D, Hupe M, Hohensteiner S, Becker F, Joerg V, et al.
Urol Oncol . 2019 Jun; 37(9):576.e1-576.e10. PMID: 31178279
Introduction: Simply applicable biomarkers for prostate cancer patients predicting the clinical course are urgently needed. Recently, TRIM24 has been identified to promote androgen receptor signaling and to correlate with an...
10.
Ellebrecht D, Kuempers C, Horn M, Keck T, Kleemann M
Surg Endosc . 2018 Sep; 33(6):1811-1817. PMID: 30242465
Background: Histological analysis of surgical specimen is the gold standard for cancer classification. In particular, frozen histological diagnosis of vague peritoneal spots or uncertain excision of tumors plays a crucial...